Systems pharmacology uncovers Janus functions of botanical drugs: activation of host defense system and inhibition of influenza virus replication
暂无分享,去创建一个
Yonghua Wang | Xue Xu | Yan Li | Bohui Li | Weiyang Tao | Xue Xu | Xiuxiu Li | Xia Wang | Yan Li | W. Tao | Yonghua Wang | Ling Yang | Bohui Li | Xia Wang | Xiuxiu Li | Ling Yang
[1] J. Rollinger,et al. Influenza neuraminidase: a druggable target for natural products. , 2012, Natural product reports.
[2] X. Chen,et al. TTD: Therapeutic Target Database , 2002, Nucleic Acids Res..
[3] H. Simmonds,et al. Importance of Ribonucleotide Availability to Proliferating T-lymphocytes from Healthy Humans , 1995, The Journal of Biological Chemistry.
[4] L. Simonsen,et al. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. , 1998, The Journal of infectious diseases.
[5] T. Yoshikawa,et al. Systemic cytokine responses in patients with influenza-associated encephalopathy. , 2003, The Journal of infectious diseases.
[6] W. Jia,et al. Anti‐influenza agents from plants and traditional Chinese medicine , 2006, Phytotherapy research : PTR.
[7] Y. Li,et al. Studies of benzothiadiazine derivatives as hepatitis C virus NS5B polymerase inhibitors using 3D-QSAR, molecular docking and molecular dynamics. , 2010, Current medicinal chemistry.
[8] David E. Swayne,et al. Characterization of the Reconstructed 1918 Spanish Influenza Pandemic Virus , 2005, Science.
[9] Yan Wang,et al. Antioxidant and antibacterial activity of two compounds (forsythiaside and forsythin) isolated from Forsythia suspensa , 2008, The Journal of pharmacy and pharmacology.
[10] Xue Xu,et al. A System-Level Investigation into the Mechanisms of Chinese Traditional Medicine: Compound Danshen Formula for Cardiovascular Disease Treatment , 2012, PloS one.
[11] M. Yano,et al. Effects of inhibitors of Toll-like receptors, protease-activated receptor-2 signalings and trypsin on influenza A virus replication and upregulation of cellular factors in cardiomyocytes. , 2011, The journal of medical investigation : JMI.
[12] D. C. Kim,et al. Anti-listerial compounds from Asari Radix , 2010, Archives of pharmacal research.
[13] J. Lehár,et al. Systematic discovery of multicomponent therapeutics , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[14] R. Lamb,et al. Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block , 1993, Journal of virology.
[15] Sander Kersten,et al. Roles of PPARs in health and disease , 2000, Nature.
[16] A. Riva,et al. Topical anti‐inflammatory activity of extracts and compounds from Hypericum perforatum L. , 2007, The Journal of pharmacy and pharmacology.
[17] I. Erlund. Review of the flavonoids quercetin, hesperetin, and naringenin. Dietary sources, bioactivities, bioavailability, and epidemiology , 2004 .
[18] I. Clark,et al. Current work and future possibilities for the management of severe influenza: using immunomodulatory agents that target the host response , 2011 .
[19] S. Cuzzocrea,et al. THE ROLE OF ENDOGENOUS AND EXOGENOUS LIGANDS FOR THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA (PPAR-&agr;) IN THE REGULATION OF INFLAMMATION IN MACROPHAGES , 2009, Shock.
[20] J. Lehár,et al. Multi-target therapeutics: when the whole is greater than the sum of the parts. , 2007, Drug discovery today.
[21] W. Jäger,et al. Investigations of animal blood samples after fragrance drug inhalation by gas chromatography/mass spectrometry with chemical ionization and selected ion monitoring. , 1991, Biological mass spectrometry.
[22] Yuwu Tan,et al. [A preliminary analysis on the detoxified recipe and medicines for aconite intoxication in Wu shi er bing fang (Formularies for 52 kinds of disorders)]. , 2002, Zhonghua yi shi za zhi.
[23] Shang-Tzen Chang,et al. Antifungal activity of essential oil and its constituents from Calocedrus macrolepis var. formosana Florin leaf against plant pathogenic fungi. , 2008, Bioresource technology.
[24] D. Richman,et al. Confronting the emergence of drug-resistant HIV type 1: impact of antiretroviral therapy on individual and population resistance. , 2005, AIDS research and human retroviruses.
[25] G. Du,et al. Anti-influenza virus activities of flavonoids from the medicinal plant Elsholtzia rugulosa. , 2008, Planta medica.
[26] Charles J. Russell,et al. Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[27] R. Davis,et al. Activation of p38 MAP kinase in T cells facilitates the immune response to the influenza virus. , 2000, Molecular immunology.
[28] Chen Shao-hong,et al. Chinese Patent Medicines Containing Eighteen Incompatible Herbs or Nineteen Mutual Antagonistic Herbs in Pharmacopoeia of People's Republic of China(volume I,2010) , 2011 .
[29] Xiaofei Shang,et al. Lonicera japonica Thunb.: Ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine , 2011, Journal of Ethnopharmacology.
[30] H. Simmonds,et al. T-lymphocytes from AIDS Patients Are Unable to Synthesize Ribonucleotides de Novo in Response to Mitogenic Stimulation , 1995, The Journal of Biological Chemistry.
[31] Sheng-jun Dai,et al. New alkaloids from Forsythia suspensa and their anti-inflammatory activities. , 2009, Planta medica.
[32] Paul T Tarr,et al. Regulation of Multidrug Resistance-associated Protein 2 (ABCC2) by the Nuclear Receptors Pregnane X Receptor, Farnesoid X-activated Receptor, and Constitutive Androstane Receptor* , 2002, The Journal of Biological Chemistry.
[33] E. Park,et al. Quercetin inhibits expression of inflammatory cytokines through attenuation of NF-κB and p38 MAPK in HMC-1 human mast cell line , 2007, Inflammation Research.
[34] J. Blumenstock,et al. Global Analysis of Gene Expression: Methods, Interpretation, and Pitfalls , 2002, Nephron Experimental Nephrology.
[35] V. Baladandayuthapani,et al. Targeting cell signaling pathways for drug discovery: An old lock needs a new key , 2007, Journal of cellular biochemistry.
[36] Shaojiang Song,et al. A New Compound from Forsythia suspensa (Thunb.) Vahl with Antiviral Effect on RSV , 2002, Journal of herbal pharmacotherapy.
[37] Su-Jin Park,et al. Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities. , 2009, Bioorganic & medicinal chemistry.
[38] Lu Huang,et al. Update of TTD: Therapeutic Target Database , 2009, Nucleic Acids Res..
[39] I. Roots,et al. St. John's wort and its constituent hyperforin concordantly regulate expression of genes encoding enzymes involved in basic cellular pathways , 2005, Pharmacogenetics and genomics.
[40] Zhi-xiang Shen,et al. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia , 2008, Proceedings of the National Academy of Sciences.
[41] A. Moscona. Neuraminidase inhibitors for influenza. , 2005, The New England journal of medicine.
[42] Hua Yu,et al. A Novel Chemometric Method for the Prediction of Human Oral Bioavailability , 2012, International journal of molecular sciences.
[43] B. McManus,et al. Toll-Like Receptor 4-Mediated Activation of p38 Mitogen-Activated Protein Kinase Is a Determinant of Respiratory Virus Entry and Tropism , 2010, Journal of Virology.
[44] J. Stamler,et al. NOS: Modulator, not mediator of cardiac performance , 1999, Nature Medicine.
[45] Stefano Forli,et al. Virtual screening with AutoDock: theory and practice , 2010, Expert opinion on drug discovery.
[46] Jean-Guy Berrin,et al. Deglycosylation by small intestinal epithelial cell β-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans , 2003, European journal of nutrition.
[47] K. Kinoshita,et al. Anti-influenza virus activity of biflavonoids. , 2007, Bioorganic & medicinal chemistry letters.
[48] Q. Wei,et al. Effects of chlorogenic acid, an active compound activating calcineurin, purified from Flos Lonicerae on macrophage. , 2004, Acta pharmacologica Sinica.
[49] Peng Jiang,et al. Molecular networks for the study of TCM Pharmacology , 2010, Briefings Bioinform..
[50] Ting-Chao Chou,et al. Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies , 2006, Pharmacological Reviews.
[51] Hyun Pyo Kim,et al. Anti-inflammatory activity of the major constituents ofLonicera japonica , 1995 .
[52] J. Davis,et al. Quercetin reduces susceptibility to influenza infection following stressful exercise. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.
[53] Edward D. Karoly,et al. Identification of gene biomarkers for respiratory syncytial virus infection in a bronchial epithelial cell line , 2008, Genomic Medicine.
[54] Chang Jong Kim,et al. Anti-inflammatory activity of arctigenin from Forsythiae Fructus. , 2008, Journal of ethnopharmacology.
[55] R. Kim,et al. Human Organic Anion Transporting Polypeptide-C (SLC21A6) Is a Major Determinant of Rifampin-Mediated Pregnane X Receptor Activation , 2003, Journal of Pharmacology and Experimental Therapeutics.
[56] B. Cao,et al. Oseltamivir Compared With the Chinese Traditional Therapy Maxingshigan–Yinqiaosan in the Treatment of H1N1 Influenza , 2011, Annals of Internal Medicine.
[57] A. Aderem,et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[58] C. Ghelardini,et al. Menthol: a natural analgesic compound , 2002, Neuroscience Letters.
[59] S. Akira,et al. Pathogen Recognition and Innate Immunity , 2006, Cell.
[60] Ralf J. Sommer,et al. The evolution of signalling pathways in animal development , 2003, Nature Reviews Genetics.
[61] C. China Pharmacopoeia,et al. Pharmacopoeia of the People's Republic of China , 2010 .
[62] Adriano Lazzarin,et al. Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial , 2009, The Lancet.
[63] Pedro Alexandrino Fernandes,et al. Protein–ligand docking: Current status and future challenges , 2006, Proteins.
[64] J. Simon,et al. Antibacterial activity of hyperforin from St John's wort, against multiresistant Staphylococcus aureus and gram-positive bacteria , 1999, The Lancet.
[65] C. Iacobuzio-Donahue,et al. Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. , 2007, Cancer research.
[66] M. Cosentino,et al. Anti-AIDS agents. 46. Anti-HIV activity of harman, an anti-HIV principle from Symplocos setchuensis, and its derivatives. , 2001, Journal of natural products.
[67] R. Bromilow,et al. cis-Jasmone induces accumulation of defence compounds in wheat, Triticum aestivum. , 2008, Phytochemistry.
[68] Ravi Iyengar,et al. Network analyses in systems pharmacology , 2009, Bioinform..
[69] Suppression of immunoglobulin production by a novel dihydroorotate dehydrogenase inhibitor, S-2678. , 2008, European journal of pharmacology.
[70] A. Patapoutian,et al. More than cool: Promiscuous relationships of menthol and other sensory compounds , 2006, Molecular and Cellular Neuroscience.
[71] R. Pan,et al. An LC-MS/MS method for determination of forsythiaside in rat plasma and application to a pharmacokinetic study. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[72] J. Taubenberger,et al. The pathology of influenza virus infections. , 2008, Annual review of pathology.
[73] G. Rimmelzwaan,et al. In vitro Effect of Bioactive Compounds on Influenza Virus Specific B‐ and T‐Cell Responses , 2002, Scandinavian journal of immunology.
[74] Zhide Hu,et al. Simultaneous determination of some active ingredients in anti-viral preparations of traditional Chinese medicine by micellar electrokinetic chromatography. , 2004, Biomedical chromatography : BMC.
[75] J. Calixto,et al. Anti-inflammatory compounds of plant origin. Part I. Action on arachidonic acid pathway, nitric oxide and nuclear factor kappa B (NF-kappaB). , 2003, Planta medica.
[76] D. Gemsa,et al. Influenza A virus infection of macrophages. Enhanced tumor necrosis factor-alpha (TNF-alpha) gene expression and lipopolysaccharide-triggered TNF-alpha release. , 1991, Journal of immunology.
[77] Hua Yu,et al. A Systematic Prediction of Multiple Drug-Target Interactions from Chemical, Genomic, and Pharmacological Data , 2012, PloS one.
[78] P. D’Aquila,et al. Anti-inflammatory activity of linalool and linalyl acetate constituents of essential oils. , 2002, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[79] K. Woo,et al. Chemistry and biological activities of caffeic acid derivatives from Salvia miltiorrhiza. , 2005, Current medicinal chemistry.
[80] K. Hua,et al. Study on the antiinflammatory activity of essential oil from leaves of Cinnamomum osmophloeum. , 2005, Journal of agricultural and food chemistry.
[81] S. Baylin,et al. Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? , 2006, Nature Reviews Cancer.
[82] R. Olsen,et al. Identification of Direct Protein Targets of Small Molecules , 2010, ACS chemical biology.
[83] C. Cho,et al. Study of the anti-proliferative effects and synergy of phthalides from Angelica sinensis on colon cancer cells. , 2008, Journal of ethnopharmacology.
[84] R. Obach,et al. Examination of 209 Drugs for Inhibition of Cytochrome P450 2C8 , 2005, Journal of clinical pharmacology.
[85] Susumu Goto,et al. KEGG for representation and analysis of molecular networks involving diseases and drugs , 2009, Nucleic Acids Res..
[86] G. Tu,et al. Qualitative and quantitative analyses of three bioactive compounds in different parts of Forsythia suspensa by high-performance liquid chromatography-electrospray ionization-mass spectrometry , 2008 .
[87] M. Morris,et al. Effect of flavonoids on MRP1-mediated transport in Panc-1 cells. , 2003, Journal of pharmaceutical sciences.
[88] R. Krug,et al. Induction of Apoptosis by Influenza Virus , 1998 .
[89] De-Quan Yu,et al. The structure and absolute configuration of Shuangkangsu: a novel natural cyclic peroxide from Lonicera japonica (Thunb.) , 2008, Journal of Asian natural products research.
[90] Tingjun Hou,et al. Recent development and application of virtual screening in drug discovery: an overview. , 2004, Current pharmaceutical design.
[91] W G Laver,et al. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. , 1997, Journal of the American Chemical Society.
[92] Jang-Gi Choi,et al. Luteolin Isolated from the Flowers of Lonicera japonica Suppresses Inflammatory Mediator Release by Blocking NF-κB and MAPKs Activation Pathways in HMC-1 Cells , 2010, Molecules.
[93] Wen-yue Jiang,et al. Therapeutic wisdom in traditional Chinese medicine: a perspective from modern science. , 2005, Trends in pharmacological sciences.
[94] Trey Ideker,et al. Cytoscape 2.8: new features for data integration and network visualization , 2010, Bioinform..
[95] N. Cox,et al. Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. , 2007, The Journal of infectious diseases.